Electrophosphorescent devices with fac-tris(2-phenylpyridine)iridium as the green emitting dopant have been fabricated with a variety of hole and exciton blocking materials. A device with aluminum(III)bis(2-methyl-8-quinolinato)4-phenylphenolate (BAlq) demonstrates an efficiency of 19 cd/A with a projected operational lifetime of 10 000 h, operated at an initial brightness of 500 cd/m2; or 50 000 h normalized to 100 cd/m2. An orange-red electrophosphorescent device with iridium(III) bis(2-phenylquinolyl-N,C2′)acetylacetonate as the dopant emitter and BAlq as the hole blocker demonstrates a maximum efficiency of 17.6 cd/A with a projected operational lifetime of 5000 h at an initial brightness of 300 cd/m2; or 15 000 h normalized to 100 cd/m2. The average voltage increase for both devices is <0.3 mV/h. The device operational lifetime is found to be inversely proportional to the initial brightness, typical of fluorescent organic light emitting devices.
No takes yet. Share an insight, caveat, or question.
Kwong et al. (2002) studied this question.
Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context: